Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Monica Bodd"'
Autor:
Scott Antonia, Jeffrey Clarke, Thomas Stinchcombe, John Hartman, Jeffrey Crawford, Monica Bodd, Susan Locke, Kris Herring, Neal Ready, Jesse Troy, Chakita Williams, Steven Wolf, Thomas LeBlanc
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/6e7012c1baf340f48033297e799e7164
Publikováno v:
Blood. 140:13267-13268
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c055b9d34914fa18e227a21c73980f7
https://doi.org/10.1182/blood-2022-165372
https://doi.org/10.1182/blood-2022-165372
Autor:
Monica Bodd, Patrick Connor Johnson, Andrew M. Brunner, Matthew J. Reynolds, Amir T. Fathi, Areej El-Jawahri, Ashley M. Nelson, Sabah Gillani, Elizabeth Daskalakis, Tejaswini Dhawale, Richard Newcomb, Rachel Plotke, Thomas W. LeBlanc, Emma C. Deary, Lauren Goldschen, Hermioni L. Amonoo, Daniel Yang, Lauren Heuer
Publikováno v:
Blood advances. 6(7)
Patients diagnosed with acute myeloid leukemia (AML) face sudden-onset life-threatening disease that requires intensive treatments. Although their early disease trajectory is characterized by significant, toxic side effects, limited data are availabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a976df490fe26b5c2af2c3606303ae1
https://pubmed.ncbi.nlm.nih.gov/34768282
https://pubmed.ncbi.nlm.nih.gov/34768282
Autor:
Ashley M. Nelson, Thomas W. LeBlanc, Lauren Goldschen, Hermioni L. Amonoo, Andrew M. Brunner, Daniel Yang, Lauren Heuer, Areej El-Jawahri, Monica Bodd, P. Connor Johnson, Richard Newcomb, Elizabeth Daskalakis, Sabah Gillani, Amir T. Fathi, Tejaswini Dhawale, Matthew J. Reynolds, Emma C. Deary
Publikováno v:
Blood. 138:4131-4131
Background: Patients with acute myeloid leukemia (AML) who receive intensive chemotherapy must cope with immense physical and psychological symptoms associated with a variety of patient-reported outcomes (PROs) such as quality of life (QOL). Although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cab320e264bddf4846bc75fc92b1ac20
https://doi.org/10.1182/blood-2021-151895
https://doi.org/10.1182/blood-2021-151895
Autor:
Jeffrey M. Clarke, Jeffrey Crawford, Chakita Williams, Scott J. Antonia, Thomas W. LeBlanc, Jesse D. Troy, Susan C. Locke, Neal Ready, John Hartman, Monica Bodd, Steven Wolf, Kris Herring, Thomas E. Stinchcombe
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundThere are limited published real-world data about patient-reported outcomes with immunotherapies (IO) in metastatic non-small cell lung cancer (mNSCLC). We describe the patient experience with first-line IO-based treatments vs. chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d91ff16730aaf11fd2f10935f65e0c0
https://doi.org/10.1136/jitc-2021-sitc2021.636
https://doi.org/10.1136/jitc-2021-sitc2021.636
Publikováno v:
Medical Education. 55:642-642
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3a97362cc048f54e960a8a04fa59b7
https://doi.org/10.1111/medu.14499
https://doi.org/10.1111/medu.14499